Skip to main navigation
Skip to search
Skip to main content
University of Canberra Research Portal Home
Search content at University of Canberra Research Portal
Home
Profiles
Research output
Projects
Press/Media
Activities
Research units
Prizes
Student theses
Partner status and survival after cancer: A competing risks analysis
Paramita Dasgupta
, Gavin Turrell
, Joanne F. Aitken
, Peter D. Baade
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Partner status and survival after cancer: A competing risks analysis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Causes of Mortality
100%
Competing Risk Analysis
100%
Partner Status
100%
Competing Mortality
100%
Mortality Risk
66%
High Mortality
66%
Cancer Mortality
66%
Cumulative Probability of Death
66%
High Risk
33%
Queensland Australia
33%
Increased Mortality
33%
Cause of Death
33%
In Cancer
33%
Survival Benefit
33%
Population-based
33%
Cancer Risk
33%
Cancer Types
33%
Mortality Burden
33%
Cancer Diagnosis
33%
Melanoma
33%
All Cancer
33%
Breast
33%
Incident Cases
33%
Cause-specific
33%
Adjusted Hazard Ratio
33%
People with Cancer
33%
Cancer-specific
33%
Age-adjusted
33%
Flexible Parametric Model
33%
Cancer Registry
33%
Age-stage
33%
Primary Cancer
33%
Cause-specific Hazard
33%
Risk Model
33%
Cancer Management
33%
Site of Death
33%
Non-cancer Death
33%
Prognostic Importance
33%
Hazard Probability
33%
Mathematics
Risk Analysis
100%
Cumulative Probability
100%
Competing Risk
100%
Hazard Ratio
50%
Parametric
50%
Competing Risk Model
50%
Earth and Planetary Sciences
Queensland
100%
Risk Analysis
100%
Australia
50%
Agricultural and Biological Sciences
Risk Analysis
100%
Malignant Neoplasm
100%
Biochemistry, Genetics and Molecular Biology
Cancer Mortality
100%
Cancer Registry
100%
Nursing and Health Professions
Malignant Neoplasm
100%
Cancer Diagnosis
14%
Melanoma
14%
Hazard Ratio
14%
Cancer Registry
14%
Primary Tumor
14%
Cancer Mortality
14%